MRTX
Mirati Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Charles M. Baum
IPO Date
2013-07-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Mirati Therapeutics, Inc.
CEO
Charles M. Baum
IPO Date
2013-07-15
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 1,413,475 |
| $0.00 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 8,717 | $58.00 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 6,333 | $0.00 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 9,702 | $0.00 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 35,000 | $4.35 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 10,716 | $45.66 |
| 23 Jan 2024 | Hasnain Faheem | director | D-Return | Disposed | 10,000 | $49.20 |
| 23 Jan 2024 | CARTER BRUCE L A | director | D-Return | Disposed | 6,021 | $58.00 |
| 23 Jan 2024 | CARTER BRUCE L A | director | D-Return | Disposed | 4,444 | $0.00 |